Aditya Birla
Aditya Birla Money Limited
  • SENSEX 36693.6999.36 0.27%
  • NIFTY 10802.7034.65 0.32%
Get Quotes
Last Update : 13 Jul
Krebs Biochemicals & Industries Ltd
(Public, BOM:500038)
Industry: Pharmaceuticals - Indian - Bulk Drugs
Sector: Pharmaceuticals
Price
Rs. 73.55
-1.5%
  • Technical Analysis
  • Benchmark
BSE NSE
  • 1 Day
  • 5 Day
  • 1 Mon
  • 3 Mon
  • 6 Mon
  • 1 Yr
KREBS BIOCHM Industry
Average
Market Cap. 146.57 146.57
Beta 0.61 0.61
EPS (TTM) 0.00 0.00
P/E Ratio (TTM) 0.00 0.00
Dividend Yield (TTM) 0.00 0.00
Institutions 0.00 0.00
Book Value -5.64 
P/B -13.24 
Div(%) 0.00  -
Face Value 10.00 
Related News
[30-Jun-2020] Krebs Biochemicals & Industries Ltd - Closure of Trading Window
[30-Jun-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Trading Window
[16-Jun-2020] Krebs Biochemicals & Industries Ltd - Announcement under Regulation 30 (LODR)-Meeting Updates
[16-Jun-2020] Krebs Biochemicals & Industries Ltd - Updated Submission Of Quick Result For Year Ended 31St March, 2020
[15-Jun-2020] Krebs Biochemicals & Industries reports standalone net loss of Rs 6.16 crore in the March 2020 quarter
[15-Jun-2020] Krebs Biochemicals & Industries Ltd - Outcome Of Board Meeting Held On 15Th June, 2020
[15-Jun-2020] Krebs Biochemicals & Industries Ltd - Submission Of Qusubmission Of Quick Result.
[12-Jun-2020] Krebs Biochemicals & Industries to hold board meeting
[11-Jun-2020] Krebs Biochemicals & Industries Ltd - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
[11-Jun-2020] Krebs Biochemicals & Industries Ltd - Board Meeting Intimation for Notice Of Board Meeting To Be Held On Monday, 15Th June 2020
[28-May-2020] Krebs Biochemicals & Industries Ltd - Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)
[28-May-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Corporate Insolvency Resolution Process
[27-May-2020] Krebs Biochemicals & Industries Ltd leads losers in 'B' group
[22-May-2020] Krebs Biochemicals & Industries Ltd leads gainers in 'B' group
[22-May-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Disclosure under SEBI Takeover Regulations
[20-May-2020] Krebs Biochemicals & Industries Ltd - Announcement under Regulation 30 (LODR)-Allotment
[20-May-2020] Krebs Biochemicals & Industries Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
[20-May-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Allotment of Securities
[13-May-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Disclosure under SEBI Takeover Regulations
[04-May-2020] Krebs Biochemicals & Industries Ltd - Submission Of Certificate Under Reg. 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31.03.2020
[04-May-2020] Krebs Biochemicals & Industries Ltd - Statement Of Investor Complaints For The Quarter Ended March 2020
[30-Apr-2020] Krebs Biochemicals & Industries Ltd - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Regards Appointment Of Chief Financial Officer And Key Managerial Personnel
[30-Apr-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Appointment
[27-Apr-2020] Krebs Biochemicals & Industries Ltd - Submission Of Compliance Certificate For The Half Year Ended 31St March, 2020
[15-Apr-2020] Bombay Rayon Fashions Ltd leads gainers in 'B' group
[30-Mar-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Trading Window
[29-Mar-2020] Krebs Biochemicals & Industries Ltd - Closure of Trading Window
[05-Feb-2020] Krebs Biochemicals & Industries Ltd - Outcome Of Board Meeting Held On 5Th February, 2020-Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015.
[05-Feb-2020] Krebs Biochemicals & Industries Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
[05-Feb-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Outcome of Board Meeting
[03-Feb-2020] Krebs Biochemicals & Industries to hold board meeting
[03-Feb-2020] Krebs Biochemicals & Industries Ltd - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
[03-Feb-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Shareholders meeting
[01-Feb-2020] Krebs Biochemicals & Industries reports standalone net loss of Rs 7.28 crore in the December 2019 quarter
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Outcome Of Board Meeting Held On 1St February, 2020
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Quick Results Submission For The Quarter Ended 31St December, 2019
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Submission Of Scrutinizers Report On The Voting Results Of The Extra Ordinary General Meeting.
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Outcome Of The Extra Ordinary General Meeting
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Closure Of Trading Window.
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Closure of Trading Window
[01-Feb-2020] Krebs Biochemicals & Industries Ltd - Krebs Biochemicals and Industries Limited - Outcome of Board Meeting
[25-Jan-2020] Krebs Biochemicals & Industries schedules board meeting
[24-Jan-2020] Krebs Biochemicals & Industries Ltd - Board Meeting Intimation for Notice Of Board Meeting To Be Held On Saturday, 1St February 2020 Under Regulation 29 Of SEBI (LODR) Regulations, 2015
[16-Jan-2020] Krebs Biochemicals & Industries Ltd leads gainers in 'B' group
  • CONTACT US

For Broking services call 1800-270-7000 (Toll free) -
(9 am-11:30pm- Mon-Fri &
9am-9pm- Sat & Sun)
For Call N Trade
Call 1800 108 9999 & Dial 1
(9am-11:30pm)

Request a Call Back

Broking & Commodity:
care.stocksandsecurities@
adityabirlacapital.com
Depository Operations:
dpcare.stocksandsecurities@
adityabirlacapital.com

Get to a branch closest to you

 ABML Branches
Locate Us

To reach us for any of our services, SMS the below short codes to 567679

  1. Broking/Distribution SMS: ABM to 567679
  2. Franchisee Partner: ABM to 567679
  3. Portfolio Management Services: ABMCS 567679

Share with us your valuable
feedback

Click Here

ATTENTION INVESTORS :

Securities Broking is through Aditya Birla Money Limited: SEBI Registration No. NSE/BSE/MCX/NCDEX:INZ000172636 ; NSDL /CDSL: IN-DP-17-2015. PMS - INP 000003757, Research Analyst –INH000002145, Investment Adviser - INA000009214. Central Insurance Repository Limited: IRDA/IR2/2014/312. Investments in securities market are subject to market risks, read all the related documents carefully before investing. Please read the risk disclosure document, rights and obligations, guidance note, Do’s and Don’ts and policies and procedure carefully before making any investment decision. Brokerage will not exceed the SEBI prescribed limit. Margins as prescribed by Exchange / SEBI will be applicable.
Corporate Office: Sai Sagar, 2nd & 3rd Floor, Plot No.M-7, Thiru-Vi-Ka (SIDCO) Industrial Estate, Guindy, Chennai 600032. Regd. office: Indian Rayon Compound, Veraval, Gujarat - 362 266 | E-mail: care.stocksandsecurities@adityabirlacapital.com | CIN L65993GJ1995PLC064810 | Tel: +91-44-49490000 / 4949 0200 | Website: stocksandsecurities.adityabirlacapital.com